News
-
MDIC White paper on "Best Practices for Communicating Benefit, Risk and Uncertainty"
MDIC is seeking public comments on its white paper, Best Practices for Communicating Benefit, Risk and Uncertainty. This paper will be part of a larger Framework for Patient Input in Medical Device Clinical Trials aiming to be published in Fall 2020.
-Read more-
-
ERC Starting Grant for hi-fi cardiovascular modeling from super-fast MRI
The VPHi member, Cristóbal Bertoglio, from University of Groningen has recently been awarded an ERC Starting Grant, called CardioZoom that aims to make possible quantitative MRIs of thin cardiovascular structures at very short MRI scan times.
-Read more-
-
Prestigious FDA award allocated to group that developed the V&V 40 standard
The VPH Institute is proud to announce that some industry members of the Avicenna Alliance have recently received the FDA Crosscutting Group Honor Award.
-Read more-
-
Publication of call for tender 'Antisuperbugs'
A call for tender “Antisuperbugs” has been published by six European procuring entities under the lead of our supporting member - Agència de Qualitat i Avaluació Sanitària de Catalunya (AQuAS).
-Read more-
-
In Silico Trials: a systematic approach to the assessment of model credibility
At the last ESB conference in Vienna, our president Marco Viceconti gave an inspiring perspective talk on the recent developments in in silico medicine.
-Read more-
-
Virtual bodies for real drugs: in silico clinical trials are the future
This article published by the Medical Futurist offers a nice overview of the potential of in silico medicine in transforming the healthcare system, from drug development to the implementation of more efficient medical treatments.
-Read more-
